Skip to main content
. 2012 Aug 17;7(8):e40690. doi: 10.1371/journal.pone.0040690

Figure 1. Phase-contrast analysis of Elesclomol-treated melanoma cells.

Figure 1

Phase-contrast images of a pigmented (WM852) and an amelanotic (C32) melanoma cell line treated for 12 hr with drug vehicle (DMSO), or a low (20 nM), or high dose (500 nM) of Elesclomol (ELM). (Images were captured at 20× magnification).